Showing 541-550 of 2410 results for "".
Molecular Imaging Biomarkers in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/molecular-imaging-biomarkers-in-dementia/31729/Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.The Immune Stroke Spectrum: Navigating Inflammatory Cerebrovascular Disorders
https://practicalneurology.com/diseases-diagnoses/stroke/the-immune-stroke-spectrum-navigating-inflammatory-cerebrovascular-disorders/49163/This review provides a concise overview of commonly encountered inflammatory cerebrovascular disorders, highlighting their clinical features, diagnostic challenges, and treatment strategies, and emphasizing that despite their complexity, early recognition and systematic management often lead to fFriedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Neuroimaging Biomarkers in Alzheimer Disease and Related Dementias: From Structural MRI to Amyloid and Tau PET
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuroimaging-biomarkers-in-alzheimer-disease-and-related-dementias-from-structural-mri-to-amyloid-and-tau-pet/56376/This practical guide explains how multimodal neuroimaging refines the diagnosis of Alzheimer disease, frontemporal dementia, dementia with Lewy bodies, and vascular dementia.Meningeal Enhancement Seen on Workup for Memory Loss
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/meningeal-enhancement-seen-on-workup-for-memory-loss/30222/Inflammation in the context of memory loss reminds us of the importance of checking opening pressure on lumbar puncture.Relapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Update on Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-on-refractory-status-epilepticus/30758/The first priority for the consulting neurologist is confirming the diagnosis. Treating any underlying disease does far more to improve outcome than mere suppression of seizures. Treatment options exist for prolonged SE, but clinicians must be realistic with families.